Immunogenic cancer screening test

摘要

The present disclosure relates to a method for determining the risk of developing cancer, including quantifying the subject HLA triplet (HAT) that can be coupled to a T cell epitope in an amino acid sequence of a tumor associated antigen. The present disclosure also relates to a method of treating an object determined to be high risk of developing cancer.No selection